We thank Drs Kuhn and Barker for their letter and for raising issuesimportant to the interpretation of the results of our study.1 Thefirst issue is the statistical analysis. For comparison of the preinjectiondata with the postinjection data, we used a nonparametric test (Wilcoxon ranksum test) for paired samples. For each comparison, we used data only for thosepatients who contributed preinjection and postinjection measurements. Thisis why the mean visual acuities at 2 weeks and 6 weeks were identical butwith different P values; different patients showed up for thefollow-up examinations at 2 weeks and at 6 weeks.
Jonas JB, Degenring RF, Kreissig I. Intravitreal Injection of Triamcinolone for Diffuse MacularEdema—Reply. Arch Ophthalmol. 2004;122(7):1086–1088. doi:10.1001/archopht.122.7.1086
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: